| Focal expression of angiotensin II type 1 receptor and smooth muscle cell proliferation in the neointima of experimental vein grafts: relation to eddy blood flow. | |
| | |
MedLine Citation:
|
PMID: 10559005 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Eddy flow has been shown to promote focal smooth muscle cell (SMC) proliferation and neointimal formation in experimental vein grafts. This study focuses on whether the angiotensin II type 1 (AT(1)) receptor mediates these events. Experimental vein grafts with and without eddy flow were created in the rat. Losartan was used to assess the influence of the AT(1) receptor on SMC proliferation. In vein grafts with eddy flow, apparent focal expression of AT(1) mRNA and protein was found in the leading region of the proximal focal neointima, where eddy flow occurred, but not in the trailing region, where eddy flow diminished, at days 5, 10, 20, and 30. The rate of SMC proliferation in the leading region (10.9+/-1.4%, 19.5+/-2.2%, 12.2+/-2.0%, and 6.9+/-1.3% at these times, respectively) was significantly higher than that in the trailing region (9.5+/-1.8%, 15.3+/-2.0%, 8.2+/-1.9%, and 3.2+/-0.7%) in these vein grafts. When eddy flow was prevented in engineered vein grafts, no apparent location difference was found in the distribution of AT(1) receptor mRNA and protein in the neointima, and the rate of SMC proliferation (5.3+/-1.0%, 5.8+/-0.9%, 3.4+/-1.0%, and 3.7+/-0.9% at days 5, 10, 20, and 30, respectively) was reduced significantly. In vein grafts with losartan, the rate of SMC proliferation in the leading region of the neointima (9.4+/-1.8%, 10.1+/-1.3%, 8.3+/-0.9%, and 4.2+/-0. 5% at days 5, 10, 20, and 30, respectively) was significantly lower than that in vein grafts without losartan. These results suggested that eddy flow upregulated the AT(1) receptor, which in turn mediated focal SMC proliferation in the neointima of experimental vein grafts. |
| | |
Authors:
|
S Q Liu |
Related Documents
:
|
8354585 - Heparinization of biological vascular graft reduces fibrin deposition. 7614315 - Vascular access and nephrology nursing practice: existing views and rationales for change. 62175 - Pulsatile blood-flow in arterial grafts. 18312105 - Automated end-to-side anastomosis to the middle cerebral artery: a feasibility study. 10929245 - Evaluation of the ict malaria pf test for rapid post-mortem diagnosis of plasmodium fal... 20931615 - Do abnormalities in regional cerebral blood flow in anorexia nervosa resolve after weig... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Arteriosclerosis, thrombosis, and vascular biology Volume: 19 ISSN: 1079-5642 ISO Abbreviation: Arterioscler. Thromb. Vasc. Biol. Publication Date: 1999 Nov |
Date Detail:
|
Created Date: 1999-11-30 Completed Date: 1999-11-30 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 9505803 Medline TA: Arterioscler Thromb Vasc Biol Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 2630-9 Citation Subset: IM |
Affiliation:
|
Biomedical Engineering Department, Northwestern University, Evanston, IL 60208-3107, USA. sliu@nwu.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Antihypertensive Agents / pharmacology Antimetabolites Blood Flow Velocity Bromodeoxyuridine Cell Division / drug effects, physiology Culture Techniques / methods Gene Expression / physiology Hyperplasia Jugular Veins / pathology, physiology*, transplantation* Losartan / pharmacology Male Muscle, Smooth, Vascular / chemistry, cytology*, physiology* RNA, Messenger / analysis Rats Rats, Sprague-Dawley Receptor, Angiotensin, Type 1 Receptor, Angiotensin, Type 2 Receptors, Angiotensin / genetics* Stress, Mechanical Tensile Strength Tunica Intima / chemistry, pathology, physiology |
| Chemical | |
Reg. No./Substance:
|
0/Antihypertensive Agents; 0/Antimetabolites; 0/RNA, Messenger; 0/Receptor, Angiotensin, Type 1; 0/Receptor, Angiotensin, Type 2; 0/Receptors, Angiotensin; 114798-26-4/Losartan; 59-14-3/Bromodeoxyuridine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Endothelial nuclear factor-kappaB translocation and vascular cell adhesion molecule-1 induction by c...
Next Document: Oxidized LDL stimulates matrix metalloproteinase-1 expression in human vascular endothelial cells.